Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accuracy, advertising, affirmative, aggregate, Allyn, ancillary, Australia, backlog, CCS, CFDA, compete, defense, directly, Eastern, effort, Emerging, Gaza, greater, GSS, guideline, halt, ii, inside, intraperiod, Israel, Japan, Jeanne, Latin, Mason, newly, organizational, overhead, pharmacological, promotion, PSS, reallocate, reallocated, reallocation, refusal, Rest, resubmission, sum, Supplemental, Suprane, surveillance, temporary, undue, viability, volume, Welch, withdrawal, written, Zealand
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view